Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Mitra, Debanjali ^a   Hodgkins, Paul ^b   Yen, Linnette ^b   Davis, Keith L ^a   Cohen, Russell D ^c  

^a RTI HEALTH SOLUTIONS   (United States)

^b Shire Development Inc   (United States)

^c UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MESALAZINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG COST; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; TREATMENT DURATION; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; DRUG PRESCRIPTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; MESALAMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84866504286     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-132     Document Type: Article

References (32)

1. Loftus EV, Silverstein MD, Sandborn WJ, Tremaine W, Harmsen W, Zinsmeister A. Ulcerative colitis in Olmstead county, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000, 46:336-343. 10.1136/gut.46.3.336, 1727835, 10673294.
2. American Gastroenterological Association The burden of gastrointestinal diseases. 2001, www.lewin.com/content/publications/2695.pdf., American Gastroenterological Association.
3. Kappelman MD, Rifas-Shiman SL, Porter CQ, Ollendorf DA, Sandler RS, Galanko JA, Finkelstein JA. Direct health care costs of treatment of Crohn's disease and ulcerative colitis in U.S. Children and adults. Gastroenterology 2008, 135:1907-1913. 10.1053/j.gastro.2008.09.012, 2613430, 18854185.
4. Bickston SJ, Waters HC, Dabbous O, Tang BI, Rahman M. Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients. J Manag Care Pharm 2008, 14(4):352-362.
5. Sutherland L, Roth D, Beck P, May G, Makiyama K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2006, 2:CD000544.
6. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006, 3:CD000543.
7. Kornbluth A, Sachar DB. Practice parameters committee of the American college of gastroenterology: ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. Am J Gastroenterol 2010, 105:501-523. 10.1038/ajg.2009.727, 20068560.
8. Gordis L. Conceptual and methodologic problems in measuring patient compliance. Compliance in health care 1979, Baltimore: Johns Hopkins University Press, Haynes RB, Sackett DL.
9. Haynes RB, Dantes R. Patient compliance and the conduct and interpretation of therapeutic trials. Control Clin Trials 1987, 8:12-19. 10.1016/0197-2456(87)90021-3, 3568692.
10. Kennedy S, McIntyre R, Fallu A, Lam R. Pharmacotherapy to sustain the fully remitted state. J Psychiatry Neurosci 2002, 27(4):269-280. 161661, 12174736.
11. Breen R, Thornhill JT. Noncompliance adherence with medication for psychiatric disorders. CNS Drugs 1998, 9:457-471.
12. Yen L, Klingman D, Hodgkins P. Improved adherence and persistence with once-daily lialda® therapy for ulcerative colitis in the united states: retrospective analysis of a Multiplan claims database 2010, 18-20. Texas: San Antonio, Poster presented at American college of gastroenterology annual scientific meeting.
13. Shaya FT, El Khoury AC, Wong W, Whitelaw N, Whitelaw G, Joseph RE, Cohen RD. Persistence with pharmacotherapy for gastrointestinal disease: associated costs of health care. P&T 2006, 31:657-665.
14. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006, 23:577-585. 10.1111/j.1365-2036.2006.02809.x, 16480396.
15. IMS LifeLink data on file: LifeLink health plan claims database overview and study design issues 2010, http://www.uams.edu/TRI/hsrcore/Lifelink_Health_Plan_Claims_Data_DesignIssues_wcost_April2010[1].pdf..
16. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical co-morbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-619. 10.1016/0895-4356(92)90133-8, 1607900.
18. Andrade SE, Kahler KH, Frech MPH, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15:565-574. 10.1002/pds.1230, 16514590.
19. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 2009, 25(9):2303-2310. 10.1185/03007990903126833, 19635045.
20. Grosset KA, Bone I, Grosset DG. Suboptimal medication adherence in Parkinson's disease. Mov Disord 2005, 20(11):1502-1507. 10.1002/mds.20602, 16037924.
21. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA. Electronic monitoring and counseling to improve medication adherence. Behav Res Ther 2004, 42:409-422. 10.1016/S0005-7967(03)00149-9, 14998735.
22. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2004, 50:166-171.
23. US Department of Labor, Bureau of Labor Statistics Consumer price index-all urban consumers (current series) 2011, http://data.bls.gov/PDQ/outside.jsp?survey=cu., US Department of Labor, Bureau of Labor Statistics.
24. Basu A, Manning WG. Issues for the next generation of health care cost analyses. Med Care 2009, 47(7 Suppl 1):S109-S114.
25. Fu AZ, Qiu Y, Radican L, Wells BJ. Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care 2009, 32(12):2187-2192. E-pub 2009 Sep 3, 10.2337/dc09-1128, 2782975, 19729528.
26. Wedderburn RWM. Quasi-likelihood functions, generalized linear models, and the gauss-Newton method. Biometrika 1974, 61:439-447.
27. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998, 17:283-295. 10.1016/S0167-6296(98)00025-3, 10180919.
28. Manning WG, Mullahy J. Estimating log models: to transform or not to transform?. J Health Econ 2001, 20:461-494. 10.1016/S0167-6296(01)00086-8, 11469231.
29. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005, 11(7):449-457.
30. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health 2009, 12(6):989-995. 10.1111/j.1524-4733.2009.00543.x, 19402852.
31. Newcomer R, Clay T, Luxenberg JS, Miller RH. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 1999, 47(2):215-219.
32. Losina E, Barrett J, Baron JA, Katz JN. Accuracy of medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003, 56:515-519. 10.1016/S0895-4356(03)00056-8, 12873645.